Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Houbiers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2013
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trialL Rostaing, B Charpentier, M Glyda, et al.
European Urology|November 13, 2012
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndromeFlorian M E Wagenlehner, J W Olivier van Till, Vittorio Magri, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
The Journal of Rheumatology|September 9, 2006
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritisMichiel M Zandbelt, Jos G A Houbiers, Frank H J van den Hoogen, et al.
World Journal of Urology|August 1, 2020
An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner's lesionsJos G A Houbiers, J W Olivier van Till, Mathilde Kaper, et al.
Arthritis and Rheumatism|January 30, 2010
The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazineRonald F van Vollenhoven, Jos G A Houbiers, Frank Buttgereit, et al.
Urology|March 4, 2017
Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled TrialFlorian M E Wagenlehner, J W Olivier van Till, Jos G A Houbiers, et al.
Annals of the Rheumatic Diseases|September 16, 2011
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept studyM J H Boumans, J G A Houbiers, P Verschueren, et al.
Annals of the Rheumatic Diseases|September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trialRobert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2013
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trialL Rostaing, B Charpentier, M Glyda, et al.
European Urology|November 13, 2012
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndromeFlorian M E Wagenlehner, J W Olivier van Till, Vittorio Magri, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
The Journal of Rheumatology|September 9, 2006
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritisMichiel M Zandbelt, Jos G A Houbiers, Frank H J van den Hoogen, et al.
World Journal of Urology|August 1, 2020
An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner's lesionsJos G A Houbiers, J W Olivier van Till, Mathilde Kaper, et al.
Arthritis and Rheumatism|January 30, 2010
The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazineRonald F van Vollenhoven, Jos G A Houbiers, Frank Buttgereit, et al.
Urology|March 4, 2017
Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled TrialFlorian M E Wagenlehner, J W Olivier van Till, Jos G A Houbiers, et al.
Annals of the Rheumatic Diseases|September 16, 2011
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept studyM J H Boumans, J G A Houbiers, P Verschueren, et al.
Annals of the Rheumatic Diseases|September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trialRobert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.
Pageof 1